S&P 500   5,005.77 (-0.11%)
DOW   37,986.71 (+0.56%)
QQQ   419.10 (-1.02%)
AAPL   165.30 (-1.04%)
MSFT   402.41 (-0.46%)
META   489.00 (-2.55%)
GOOGL   154.77 (-0.79%)
AMZN   176.72 (-1.39%)
TSLA   150.27 (+0.23%)
NVDA   821.94 (-2.93%)
AMD   151.60 (-2.24%)
NIO   3.87 (-3.25%)
BABA   68.80 (-0.12%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   109.22 (-2.42%)
GE   151.72 (-0.80%)
CGC   7.69 (-1.79%)
DIS   112.14 (-0.26%)
AMC   3.18 (+8.90%)
PFE   25.65 (+1.02%)
PYPL   62.22 (+0.19%)
XOM   120.52 (+1.69%)
S&P 500   5,005.77 (-0.11%)
DOW   37,986.71 (+0.56%)
QQQ   419.10 (-1.02%)
AAPL   165.30 (-1.04%)
MSFT   402.41 (-0.46%)
META   489.00 (-2.55%)
GOOGL   154.77 (-0.79%)
AMZN   176.72 (-1.39%)
TSLA   150.27 (+0.23%)
NVDA   821.94 (-2.93%)
AMD   151.60 (-2.24%)
NIO   3.87 (-3.25%)
BABA   68.80 (-0.12%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   109.22 (-2.42%)
GE   151.72 (-0.80%)
CGC   7.69 (-1.79%)
DIS   112.14 (-0.26%)
AMC   3.18 (+8.90%)
PFE   25.65 (+1.02%)
PYPL   62.22 (+0.19%)
XOM   120.52 (+1.69%)
S&P 500   5,005.77 (-0.11%)
DOW   37,986.71 (+0.56%)
QQQ   419.10 (-1.02%)
AAPL   165.30 (-1.04%)
MSFT   402.41 (-0.46%)
META   489.00 (-2.55%)
GOOGL   154.77 (-0.79%)
AMZN   176.72 (-1.39%)
TSLA   150.27 (+0.23%)
NVDA   821.94 (-2.93%)
AMD   151.60 (-2.24%)
NIO   3.87 (-3.25%)
BABA   68.80 (-0.12%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   109.22 (-2.42%)
GE   151.72 (-0.80%)
CGC   7.69 (-1.79%)
DIS   112.14 (-0.26%)
AMC   3.18 (+8.90%)
PFE   25.65 (+1.02%)
PYPL   62.22 (+0.19%)
XOM   120.52 (+1.69%)
S&P 500   5,005.77 (-0.11%)
DOW   37,986.71 (+0.56%)
QQQ   419.10 (-1.02%)
AAPL   165.30 (-1.04%)
MSFT   402.41 (-0.46%)
META   489.00 (-2.55%)
GOOGL   154.77 (-0.79%)
AMZN   176.72 (-1.39%)
TSLA   150.27 (+0.23%)
NVDA   821.94 (-2.93%)
AMD   151.60 (-2.24%)
NIO   3.87 (-3.25%)
BABA   68.80 (-0.12%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   109.22 (-2.42%)
GE   151.72 (-0.80%)
CGC   7.69 (-1.79%)
DIS   112.14 (-0.26%)
AMC   3.18 (+8.90%)
PFE   25.65 (+1.02%)
PYPL   62.22 (+0.19%)
XOM   120.52 (+1.69%)
NASDAQ:HITK

HiTech Pharmacal (HITK) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HITK stock logo

About HiTech Pharmacal Stock (NASDAQ:HITK)

Hi-Tech Pharmacal Co., Inc. is a specialty manufacturer and marketer of prescription, over-the-counter and nutritional products. The Company develops, manufactures and markets products in three categories: generics, prescription brands and over-the-counter (OTC) brands. It produces a range of products for various disease states, including glaucoma, asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, oral care and other conditions. The Company’s generic products are primarily prescription items and include oral solutions and suspensions, topical creams and ointments as well as nasal sprays. It also specializes in the manufacture of products in its sterile facility capable of producing liquid ophthalmic, otic and inhalation products. In April 2014, Akorn Inc acquired Hi-Tech Pharmacal Co., Inc.

HITK Stock News Headlines

SungEel HiTech Co. Ltd.
CM Hi-Tech Cleanroom Ltd Ordinary Shares
3 Sub-$10 Stocks to Buy for 2024
Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.
Sungwoo Hitech Co Ltd (015750)
Hi-Tech Pipes Ltd
KX Hitech Co. Ltd.
Walton Hi-Tech Industries Ltd.
Your Next Portfolio Star: Revealing 2024's Top Stock Pick
We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)
AAPICO Hitech PCL (AH)
Hi-Tech Pharmacal Co Inc (HITK)
Five Small-Cap Stocks to Own Now
See More Headlines
Receive HITK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HiTech Pharmacal and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:HITK
CUSIP
42840B10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

HITK Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of HiTech Pharmacal own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HiTech Pharmacal investors own include Ensco Rowan (ESV), Kingfisher (KGFHY), Allos Therapeutics (ALTH), Alaska Air Group (ALK), Assured Guaranty (AGO), Allergan (AGN), AGCO (AGCO), Archer-Daniels-Midland (ADM), Accuride (ACW) and Acacia Research (ACTG).

This page (NASDAQ:HITK) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners